<DOC>
	<DOCNO>NCT03018067</DOCNO>
	<brief_summary>This phase 2 , single-blind , placebo-controlled study evaluate onset-of-action , safety , efficacy RDX227675 treatment hyperkalemia . Subjects qualify randomize one four treatment group : Group 1 ( Placebo qd ) , Group 2 ( RDX227675 10 g qd ) , Group 3 ( RDX227675 20 g qd ) , Group 4 ( RDX227675 30 g qd ) .</brief_summary>
	<brief_title>A Study Evaluating Onset-of-Action , Safety , Efficacy RDX227675 Treatment Hyperkalemia</brief_title>
	<detailed_description>The study consist screen visit , 7-day treatment period , 7-day treatment-free follow-up period .</detailed_description>
	<mesh_term>Hyperkalemia</mesh_term>
	<criteria>18 85 year old , inclusive Two consecutive iSTAT K value ≥ 5.5 &lt; 6.5 mmol/L , measure minimum 60minutes apart within 1 day first RDX227675 dose Day 1 ( prior randomization ) iSTAT K value ≥ 5.5 &lt; 6.5 mmol/L Day 1 ( prior randomization ) Ability repeat blood draw effective venous catheterization Females child bear potential must negative urine pregnancy test Day 1 ( prior randomization ) Females nonpregnant , nonlactating , either postmenopausal least 12 month , documentation irreversible surgical sterilization , confirm use one acceptable contraceptive method Males must agree use appropriate method contraception document surgical sterilization Pseudohyperkalemia sign symptom Treatment K lower drug , within 7 day prior randomization Uncontrolled Type 2 diabetes , define recent historical HbA1c &gt; 10 % , hospitalization treat hyper hypoglycemia past 3 month Diabetic ketoacidosis Known hypersensitivity polystyrene sulfonate Significant cardiovascular cerebrovascular event past 2 month Severe heart failure , define NYHA ( New York Heart Association ) class IV hospitalization treat heart failure previous 3 month History bowel obstruction , swallow disorder , severe gastrointestinal disorder , major gastrointestinal surgery Major psychiatric disorder ( DSMIIIR DSMIV ) include major depression psychosis require hospitalization last 3 year . History attempt suicide uncontrolled bipolar disorder . Use investigational product within 30 day prior Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>